CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Supported self-management +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03274063
NCT03274063N/ACompleted
CompareCT.gov

Gout Self-Monitoring Aiming to Reach Target Serum Urate (Gout-SMART): Feasibility Study of Supported Self-management of Gout in Secondary Care Patients Requiring Escalation of Urate Lowering Therapy

University of Edinburgh·interventional·Posted Sep 6, 2017·Updated May 21, 2024

In Brief

A clinical study evaluating Supported self-management and Usual care for Gout. Completed, enrolled 60 participants across 1 site.

Detailed Summary

This study evaluates whether a supported self-management approach to gout is able to achieve target levels of serum urate, and better control of gout flares.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGout
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 6, 2017
Enrollment StartApr 5, 2019
Primary CompletionMar 19, 2021
Study CompletionJun 1, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 8.8 years ago

Interventions

Supported self-managementother

Participants will be supplied with urate self-testing kits. Participants will have a mobile phone application installed which will prompt the participant to perform urate self-testing, enable the clinical research team to advise on escalation of urate lowering therapy, and collect quality of life data .

Usual careother

Participants will have a mobile phone application installed which will allow the research team to collect quality of life data.